St. Jude Gets FDA Approval for Epiducer Neurostimulation Delivery System
St. Jude Medical has received FDA clearance for its Epiducer neurostimulation lead delivery system for pain management, according to a company news release.
The Epiducer system allows placement of as many as three neurostimulation leads through a single entry point.
The system also allows introduction of St. Jude Medical S-Series paddle leads through a percutaneous entry.
Read the St. Jude Medical release on approval of Epiducer.
Related Articles on Neurostimulation Therapy:
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.